HyClone  www.hyclone.com 
HyClone實驗室創(chuàng)建于1967年，總部位于風(fēng)景秀麗的美國猶他州洛根市。從為美國大學(xué)基礎(chǔ)研究中的細(xì)胞培養(yǎng)開發(fā)高質(zhì)量的胎牛血清做起，HyClone最先使用科學(xué)的收集方法和生產(chǎn)工藝生產(chǎn)出了內(nèi)毒素和血紅蛋白含量極低的高品質(zhì)血清 。我們還第一個使用了高效過濾方法，大大的提高了FBS的質(zhì)量和促生長特性 。使我們自豪的是，HyClone是唯一可以對整個血清采集和加工過程進(jìn)行完全控制的公司。
除了生產(chǎn)高質(zhì)量的動物血清之外，HyClone還提供品種眾多的細(xì)胞培養(yǎng)產(chǎn)品，包括：普通細(xì)胞培養(yǎng)基，無血清培養(yǎng)基，無蛋白培養(yǎng)基，F(xiàn)BS替代品，微載體，生物工程容器系統(tǒng)等。HyClone公司所有的產(chǎn)品生產(chǎn)均符合cGMP標(biāo)準(zhǔn)并從一九九五年起連續(xù)獲得ISO9001國際認(rèn)證。HyClone公司每年在FDA注冊為“醫(yī)學(xué)工具企業(yè)”，并被指定為醫(yī)學(xué)工具的生產(chǎn)者和合同生產(chǎn)者。
經(jīng)過三十年的發(fā)展，HyClone實驗室公司已經(jīng)成為全球領(lǐng)先的細(xì)胞培養(yǎng)產(chǎn)品供應(yīng)商。HyClone血清多年以來穩(wěn)居美國市場占有率第一。自2000年起美國ATCC對所有的HyClone血清實行免檢采購。我們大批量生產(chǎn)的液體及干粉培養(yǎng)基，無血清無蛋白培養(yǎng)基，注射用水，以及其他細(xì)胞培養(yǎng)試劑已經(jīng)被世界上大多數(shù)著名的疫苗和基因工程制藥廠商廣泛采用。通過遍布世界的營銷網(wǎng)絡(luò)，HyClone的優(yōu)秀產(chǎn)品和高質(zhì)量的服務(wù)將和廣大生命科學(xué)工作者一起推動細(xì)胞生物學(xué)技術(shù)在新世紀(jì)的更大發(fā)展。
2014年GE Healthcare完成對賽默飛三大業(yè)務(wù)的收購

HyClone's Origins 
HyClone began in 1967 when founder Dr. Rex Spendlove, then a professor at Utah State University, was studying a viral disease fatal to children, especially in developing countries. At that time, the quality of commercially available fetal bovine serum (FBS) was so poor that Dr. Spendlove was forced to develop his own methods to produce a high quality serum to meet his research needs. Recognizing a real need in the scientific community for high quality FBS, he founded a company that would meet that need.
Industry Innovator 
HyClone pioneered serum collection, filtration, and processing techniques used to produce consistently high quality, reliable serum products. To produce FBS, HyClone collects fetal bovine blood using a patented closed-system collection method that results in serum with exceptionally low levels of endotoxin and hemoglobin. HyClone pioneered the use of high retentive filtration techniques including triple 100 nm and 40 nm pore size rated filters to ensure sterility. Vertical integration of all serum collection and manufacturing processes provides complete traceability and high quality.
HyClone Continues To Lead 
HyClone has evolved into a world leader in manufacturing cell culture media, sera and bioprocess container systems. Today, HyClone serves customers worldwide from its headquarters and primary manufacturing site in Logan, Utah, sites in the United Kingdom, Belgium, China, and New Zealand, and an extensive network of sales representatives and international distributors.
HyClone is now a part of Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. We enable our customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals, and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings.
We deliver the industry's broadest selection of analytical instruments, equipment, consumables and laboratory supplies. Our growing portfolio of products includes innovative technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, fine and high-purity chemistry production, cell culture, RNA interference analysis, immunodiagnostic testing, as well as air and water quality monitoring and process control. We also give our customers the most convenient purchasing choices, including a direct sales force of 7,5000 professionals, catalogs, e-commerce and distribution partners.